Dr. Gondi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4405 Weaver Pkwy
Warrenville, IL 60555Phone+1 630-352-5350Fax+1 630-933-4357
Education & Training
University of Wisconsin Hospitals and ClinicsResidency, Radiation Oncology, 2008 - 2012
Columbia University Vagelos College of Physicians and SurgeonsClass of 2007
Certifications & Licensure
IL State Medical License 2012 - 2026
WI State Medical License 2009 - 2015- American Board of Radiology Radiation Oncology
Clinical Trials
- Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Start of enrollment: 2011 Sep 01
- Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas Start of enrollment: 2011 Dec 14
- Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer Start of enrollment: 2015 Dec 07
- Join now to see all
Publications & Presentations
PubMed
- 248 citationsHippocampal-Sparing Whole-Brain Radiotherapy: A 'How-To' Technique Using Helical Tomotherapy and Linear Accelerator-Based Intensity-Modulated RadiotherapyVinai Gondi, R. Tolakanahalli, Minesh P. Mehta, D Tewatia, Howard A. Rowley
International Journal of Radiation Oncology, Biology, Physics. 2010-11-15 - 267 citationsWhy Avoid the Hippocampus? A Comprehensive ReviewVina I. Gondi, Wolf Gan Ga. Tome, Minesh P. Mehta
Radiotherapy and Oncology. 2010-12-01 - 24 citationsHippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors.Vinai Gondi, Bruce P Hermann, Minesh P Mehta, Wolfgang A Tomé
International Journal of Radiation Oncology, Biology, Physics. 2012-07-15
Lectures
- NRG Oncology CC003: A randomized phase II/III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small cell lung cancer.2019 ASCO Annual Meeting - 6/1/2019
- NRG Oncology CC001: A phase III trial of hippocampal avoidance (HA) in addition to whole-brain radiotherapy (WBRT) plus memantine to preserve neurocognitive function (...2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
Reducing Cognitive Impairment from SCLC Brain MetastasesOctober 4th, 2023- ASTRO Updates Guideline on Radiation Therapy for Brain MetastasesJuly 12th, 2022
- Radiotherapy for Brain Metastases: ASTRO Updates GuidelinesJune 10th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
